1.38

0.00% 0.00

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $1.38, with a volume of 731.97K. It is up +0.00% in the last 24 hours and down -13.75% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$1.38

Open:

$1.41

24h Volume:

731.97K

Relative Volume:

0.95

Market Cap:

$137.49M

Revenue:

$31.20M

Net Income/Loss:

$-21.68M

P/E Ratio:

-5.6511

EPS:

-0.2442

Net Cash Flow:

$-15.52M

1W Performance:

-2.82%

1M Performance:

-13.75%

6M Performance:

-30.65%

1Y Performance:

-52.41%

1-Day Range:

$1.325

$1.41

1-Week Range:

$1.30

$1.50

52-Week Range:

$1.24

$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1080)

Industry

Medical Instruments & Supplies (56)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2026-08-11

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	1.38	139.48M	31.20M	-21.68M	-15.52M	-0.2442
ISRG Intuitive Surgical Inc	394.51	141.76B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	183.40	50.00B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	74.25	35.57B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	224.46	32.78B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	35.74	31.15B	29.14B	1.07B	1.05B	1.1956

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-16-25	Initiated	Citizens JMP	Mkt Outperform
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy

View All

Stereotaxis Inc Stock (STXS) Latest News

Aug 14, 2026

Stereotaxis, Inc. introduces MAGiC ablation tip for efficient energy delivery - Traders Union

Aug 14, 2026

Stereotaxis, Inc. SEC Filing (Aug 14, 2026) - Stock Titan

Aug 14, 2026

Aug 12, 2026

Stereotaxis, Inc. completes Robocath deal as GenesisX gains first U.S. customer - Traders Union

Aug 12, 2026

Stereotaxis robotic catheter sales surge 270% in Q2 despite revenue miss - scanx.trade

Aug 11, 2026

Transcript : Stereotaxis, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com

Aug 11, 2026

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates - The Manila Times

Aug 11, 2026

Stereotaxis Q2 revenue misses estimates, dragged by system decline - TradingView

Aug 11, 2026

Stereotaxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 11, 2026

Stereotaxis’ First U.S. GenesisX Robot to Be Installed This Fall - Stock Titan

Aug 11, 2026

BRIEF-Stereotaxis Q2 Revenue USD 7.67 Million Vs. IBES Estimate USD 8.35 Million - TradingView

Aug 11, 2026